I do not post on twitter. Please post that link here. The twitter link is of Dr JJ commenting on the successful aviptadil trial in India.
Promising results from the Zuventus trial of aviptadil for treating critically-ill COVID-19 patients in India. As new variants start to threaten hard-won vaccine immunity, COVID therapeutics are essential to rescue those who contract COVID despite best efforts at vaccination
— jjavitt@neurorxpharma.com (@jjavittneurorx1) July 7, 2021